Top Markets
#1 ADO Protocol ADO Protocol +195.96%
#2 Islamic Coin Islamic Coin +155.46%
#3 GoPlus Security GoPlus Security +55.26%
#4 Starpower Starpower +25.21%
#5 GAIB AID GAIB AID +24.67%
#6 Casper Network Casper Network +15.83%
#7 The Black Bull The Black Bull +14.10%
#8 Status Status +13.79%
#9 Verus Coin Verus Coin +13.54%
#10 Pons Pons +12.54%
Coin of the day
ADO Protocol ADO Protocol
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Addex Therapeutics Ltd Addex Therapeutics Ltd

Addex Therapeutics Ltd

ADXN
Classificação em ações #33378
Addex Therapeutics Ltd, a biopharmaceutical company in its development phase,... Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established strategic licensing and collaborative partnerships with organizations including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002, the company changed its name from Addex Pharmaceuticals Ltd to its current designation in March 2012.
Preço da ação
$0.05124204
Valor de mercado
$7.78M
Variação (1 dia)
0.51%
Variação (1 ano)
-23.73%
País
CH
Negociar Addex Therapeutics Ltd (ADXN)

Categoria

Healthcare
Lucros da Addex Therapeutics Ltd (ADXN)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Addex Therapeutics Ltd, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Addex Therapeutics Ltd de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE